STOCK TITAN
  1. Home
  2. Sec-filings
  3. CBRE
  4. [Form 4] CBRE GROUP, INC. Insider Trading Activity

CBRE (NYSE: CBRE) CEO receives 84,094-share RSU award tied to Core EPS

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CBRE Group Chair and CEO Robert E. Sulentic reported the acquisition of 84,094 shares of Class A common stock through a restricted stock unit award. The award, part of his 2025 annual equity compensation, carries no purchase price per share and reflects a grant, not an open-market buy.

The Compensation Committee certified on February 20, 2026 that the company met its Core EPS performance needed for this award to vest. These restricted stock units are scheduled to vest in full on March 5, 2028, subject to forfeiture under the terms of the award agreement. Following this transaction, Sulentic directly holds 1,348,748 shares.

Positive

  • None.

Negative

  • None.

Insights

Equity grant vests on performance, not an open-market purchase.

The filing shows Robert E. Sulentic receiving 84,094 restricted stock units as part of his 2025 annual equity award. The grant price is reported as $0.0000 per share, confirming it is compensation-based equity rather than a cash-funded share purchase.

The Compensation Committee certified the required Core EPS performance on February 20, 2026, triggering the vesting schedule. The units will vest fully on March 5, 2028, but remain subject to forfeiture under the award agreement. This is a standard long-term incentive structure and does not, by itself, signal a change in insider sentiment.

Insider SULENTIC ROBERT E
Role Chair & CEO
Type Security Shares Price Value
Grant/Award Class A Common Stock 84,094 $0.00 --
Holdings After Transaction: Class A Common Stock — 1,348,748 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SULENTIC ROBERT E
(Last) (First) (Middle)
2121 NORTH PEARL STREET
SUITE 300
(Street)
DALLAS TX 75201
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CBRE GROUP, INC. [ CBRE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chair & CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 02/20/2026 A(1) 84,094 A $0.0000 1,348,748 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted to the Reporting Person on March 5, 2025 as part of the Reporting Person's 2025 annual equity award. On February 20, 2026, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer's Core EPS performance necessary for this award to vest. As such, these restricted stock units will vest in full on March 5, 2028, subject to forfeiture in certain circumstances as set forth in the restricted stock units award agreement.
/s/ Andria Iles, Attorney-in-Fact for Robert E. Sulentic 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did CBRE (CBRE) CEO Robert Sulentic report in this Form 4?

Robert E. Sulentic reported acquiring 84,094 shares of CBRE Class A common stock via a restricted stock unit grant. This equity award is part of his 2025 annual compensation package rather than an open-market share purchase.

Is the CBRE (CBRE) Form 4 a stock purchase or an equity grant?

The Form 4 reflects an equity grant, not a stock purchase. Sulentic received 84,094 restricted stock units at a reported price of $0.0000 per share as part of his 2025 annual equity award program.

When do Robert Sulentic’s CBRE (CBRE) restricted stock units vest?

The restricted stock units are scheduled to vest in full on March 5, 2028. Vesting follows the Compensation Committee’s February 20, 2026 certification that CBRE achieved the Core EPS performance required for this award.

What performance condition applies to this CBRE (CBRE) RSU award?

The award depends on CBRE’s Core EPS performance. On February 20, 2026, the Compensation Committee certified that the necessary Core EPS performance for this 2025 equity award had been achieved, allowing the units to vest on the defined future date.

How many CBRE (CBRE) shares does Robert Sulentic hold after this transaction?

After this restricted stock unit grant, Sulentic is reported as directly owning 1,348,748 shares of CBRE Class A common stock. This figure includes the newly reported award and reflects his direct ownership position following the transaction.

Are Robert Sulentic’s CBRE (CBRE) restricted stock units subject to forfeiture?

Yes. The restricted stock units may be forfeited under certain circumstances. The filing notes they are subject to forfeiture conditions described in the restricted stock unit award agreement governing this 2025 annual equity grant.